CA2335939A1 - Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient - Google Patents
Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient Download PDFInfo
- Publication number
- CA2335939A1 CA2335939A1 CA002335939A CA2335939A CA2335939A1 CA 2335939 A1 CA2335939 A1 CA 2335939A1 CA 002335939 A CA002335939 A CA 002335939A CA 2335939 A CA2335939 A CA 2335939A CA 2335939 A1 CA2335939 A1 CA 2335939A1
- Authority
- CA
- Canada
- Prior art keywords
- patient
- composition
- body temperature
- sulfur hexafluoride
- gas mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/362—General characteristics of the apparatus related to heating or cooling by gas flow
Abstract
The present invention is directed to a method for changing the body temperature of a patient by having them hyperventilate a gas mixture containing sulfur hexafluoride and oxygen. The method may be applied to cool patients in any clinical situation where induced hypothermia is desirable or to rapidly rewarm hypothermic patients. The invention also includes the gas mixtures used in the method.
Description
COMPOSITION CONTAINING SULFUR HEXAFLUORIDE AND OXYGEN, FOR INCREASING OR
DECREASING THE
BODY TEMPERATURE OF A PATIENT
Field of the Invention The present invention is directed to noninvasive methods for rapidly changing the body temperature of a patient. This is accomplished by having the patient hyperventilate a gaseous mixture containing sulfur hexafluoride and oxygen. The invention also includes the compositions used in these methods.
Background of the Invention Patients undergoing operations that require low blood flow or circulatory arrest often must have their body temperature lowered prior to surgery in order to help protect the heart and brain. In particular, hypothermia has been induced in patients undergoing cardiac surgery and operations for cerebral aneurysms. More recently, the lowering of body temperature has been used as a technique for protecting the brain in head trauma patients and there are indications that this procedure may be useful in treating patients for hemorrhagic shock.
Unfortunately, there is, at present, no reliable noninvasive method for rapidly lowering a patient's body temperature. The present invention addresses this problem and discloses a method that can be used for rapidly inducing hypothermia or, alternatively, for rapidly warming a hypothermic patient.
Summary of the Invention The present invention is based upon the concept that respiratory heat exchange can be used to rapidly change a patient's body temperature. The method requires nothing more than standard hospital equipment such as a ventilator and a means for heating or cooling gases prior to administration to a patient.
In its first aspect, the invention is directed to a method for reducing the body temperature of a patient by administering a gas mixture comprising a combination of sulfur hexafluoride and oxygen. In order to increase the rate of heat exchange, the gas mixture is administered while the patient hyperventilates, either spontaneously or as the result of mechanical ventilation. The mixture being administered must be below the body temperature of the patient and administration is continued until the patient's temperature is reduced to the desired level.
DECREASING THE
BODY TEMPERATURE OF A PATIENT
Field of the Invention The present invention is directed to noninvasive methods for rapidly changing the body temperature of a patient. This is accomplished by having the patient hyperventilate a gaseous mixture containing sulfur hexafluoride and oxygen. The invention also includes the compositions used in these methods.
Background of the Invention Patients undergoing operations that require low blood flow or circulatory arrest often must have their body temperature lowered prior to surgery in order to help protect the heart and brain. In particular, hypothermia has been induced in patients undergoing cardiac surgery and operations for cerebral aneurysms. More recently, the lowering of body temperature has been used as a technique for protecting the brain in head trauma patients and there are indications that this procedure may be useful in treating patients for hemorrhagic shock.
Unfortunately, there is, at present, no reliable noninvasive method for rapidly lowering a patient's body temperature. The present invention addresses this problem and discloses a method that can be used for rapidly inducing hypothermia or, alternatively, for rapidly warming a hypothermic patient.
Summary of the Invention The present invention is based upon the concept that respiratory heat exchange can be used to rapidly change a patient's body temperature. The method requires nothing more than standard hospital equipment such as a ventilator and a means for heating or cooling gases prior to administration to a patient.
In its first aspect, the invention is directed to a method for reducing the body temperature of a patient by administering a gas mixture comprising a combination of sulfur hexafluoride and oxygen. In order to increase the rate of heat exchange, the gas mixture is administered while the patient hyperventilates, either spontaneously or as the result of mechanical ventilation. The mixture being administered must be below the body temperature of the patient and administration is continued until the patient's temperature is reduced to the desired level.
Typically, the sulfur hexafluoride will be present at a concentration of between 20 and 80%, with about an 80/20 ratio of sulfur hexafluoride to oxygen being preferred. It is also generally preferred that the pressure of carbon dioxide in the patient's arterial blood be maintained within the normal range during gas administration. A reduction in body temperature may be facilitated by maintaining the water vapor content of the gas mixture at low levels, preferably below 10%.
The method discussed above can, alternatively, be used for increasing the body temperature of a patient. The same mixture of sulfur hexafluoride and oxygen is administered but, rather than being cooled prior to administration, it is heated to a temperature above that of the patient. Again, administration of the mixture is maintained until the desired body temperature of the patient is achieved. As with the procedure described above, sodium hexafluoride should he maintained at a concentration of between 20 and 80%, with an 80/20 ratio of sodium hexafluoride to oxygen being preferred. A patient's arterial blood carbon dioxide pressure may be maintained within the normal range during this procedure. In order to further promote an increase in body temperature, the water vapor content of the gas mixture administered to a patient may be maintained at levels of greater than 20 or 40%.
The invention also encompasses the compositions for rapidly changing a patient's body temperature used in the methods described above. Thus, the invention includes mixtures of sulfur hexafluoride and oxygen, typically with the sulfur hexafluoride present at a concentration of 20-80%. Preferably, the composition should have about 80% sulfur hexafluoride. The most desirable concentration of water vapor will depend upon the intended use of the composition.
In cases where the composition will be used for lowering the body temperature of a patient, water vapor should, preferably, be present at a concentration of less than 10%. Compositions that will be used to warm a patient should have a concentration of water vapor of greater than 20% and, more preferably, of greater than 40%.
Detailed Description of the Invention The purpose of the present invention is to provide a simple, noninvasive method for rapidly changing the body temperature of a patient. This is accomplished by the patient hyperventilating a breathing mixture containing sulfur hexafluoride and oxygen.
The method discussed above can, alternatively, be used for increasing the body temperature of a patient. The same mixture of sulfur hexafluoride and oxygen is administered but, rather than being cooled prior to administration, it is heated to a temperature above that of the patient. Again, administration of the mixture is maintained until the desired body temperature of the patient is achieved. As with the procedure described above, sodium hexafluoride should he maintained at a concentration of between 20 and 80%, with an 80/20 ratio of sodium hexafluoride to oxygen being preferred. A patient's arterial blood carbon dioxide pressure may be maintained within the normal range during this procedure. In order to further promote an increase in body temperature, the water vapor content of the gas mixture administered to a patient may be maintained at levels of greater than 20 or 40%.
The invention also encompasses the compositions for rapidly changing a patient's body temperature used in the methods described above. Thus, the invention includes mixtures of sulfur hexafluoride and oxygen, typically with the sulfur hexafluoride present at a concentration of 20-80%. Preferably, the composition should have about 80% sulfur hexafluoride. The most desirable concentration of water vapor will depend upon the intended use of the composition.
In cases where the composition will be used for lowering the body temperature of a patient, water vapor should, preferably, be present at a concentration of less than 10%. Compositions that will be used to warm a patient should have a concentration of water vapor of greater than 20% and, more preferably, of greater than 40%.
Detailed Description of the Invention The purpose of the present invention is to provide a simple, noninvasive method for rapidly changing the body temperature of a patient. This is accomplished by the patient hyperventilating a breathing mixture containing sulfur hexafluoride and oxygen.
The method is based upon the fact that the convective component of respiratory heat exchange is directly proportional to the minute ventilation, the density of the breathing mixture (gas) and its specific heat, and the difference in temperature between exhaled and inhaled gas.
Thus, respiratory heat exchange is maximized by:
1) Increasing minute ventilation: This can be achieved by asking the patient to increase his/her tidal volumes and respiratory rate and/or by using a standard operating room or ICU ventilator in an intubated patient. The patient may be asked to hyperventilate spontaneously prior to being sedated and intubated to achieve faster rates of cooling or rewarming. If eucapnia (also known as isocapnia) is desired, carbon dioxide can be added to the breathing mixture as guided by either end-tidal or arterial pressures of carbon dioxide in the patient.
2} Increasing the density of the gas (breathing mixture): The higher the concentration of sulfur hexafluoride in the mixture, the higher the resulting gas density.
3) Increasing the specific heat of the breathing mixture: This may be accomplished by adding another gas which has a high specific heat to the mixture.
Thus, respiratory heat exchange is maximized by:
1) Increasing minute ventilation: This can be achieved by asking the patient to increase his/her tidal volumes and respiratory rate and/or by using a standard operating room or ICU ventilator in an intubated patient. The patient may be asked to hyperventilate spontaneously prior to being sedated and intubated to achieve faster rates of cooling or rewarming. If eucapnia (also known as isocapnia) is desired, carbon dioxide can be added to the breathing mixture as guided by either end-tidal or arterial pressures of carbon dioxide in the patient.
2} Increasing the density of the gas (breathing mixture): The higher the concentration of sulfur hexafluoride in the mixture, the higher the resulting gas density.
3) Increasing the specific heat of the breathing mixture: This may be accomplished by adding another gas which has a high specific heat to the mixture.
4) Increasing the difference in temperature between exhaled and inhaled gas:
In order to cool a patient, the breathing mixture to be inhaled must be cooled below the patient's body temperature; the colder the inhaled breathing gas, the higher the resulting respiratory heat loss. In order to warm a patient, the breathing mixture to be inhaled will be warmed; the warmer the inhaled breathing gas, the higher the resulting respiratory heat gain.
In addition, the content of water vapor in the breathing mixture to be inhaled can be changed to improve the efficiency of the method. For example, the content of water vapor can be decreased (e.g., down to zero) if the patient needs to be cooled; the drier the breathing mixture, the higher the evaporative heat loss. Alternatively, the content of water vapor can be increased (up to saturation) if the patient needs to be rewarmed. This will have the effect of minimizing evaporative heat loss.
In a preferred method, patients are heated or warmed using eucapnic hyperventilation with about an 80/20 sulfur hexafluoride-oxygen mixture. To cool a patient, hyperventilation is performed with a gas mixture to which C02 is added to maintain isocapnia. The gas mixture is delivered dry and at subfreezing temperature through an endotracheal tube of the type routinely used in operations. To rewarm a patient, hyperventilation is performed with a humidified and warmed gas mixture.
The gas mixtures administered to patients may be mixed in a reservoir and then delivered to patients by means of a ventilator of the sort commonly available in hospitals. In procedures designed to lower body temperature, the gas mixture may be forced through a desiccator to remove water vapor and through a heat exchanger to lower its temperature (see e.g., Beran, et al., J. App. Physiol. 39:337-340 (1975)). In procedures designed to increase body temperature, gases from a mixing reservoir may be delivered using a ventilator, humidified, and warmed by a standard electrically operated heater/humidifier system. As with cooling, rewarming will be accomplished using a gas mixture of sulfur hexafluoride and oxygen. These procedures are merely illustrative and the invention is compatible with any other method for heating or cooling gas mixtures and for effectively delivering them to a patient.
The simplest way for achieving hyperventilation will be by means of the voluntary cooperation of a patient immediately prior to their being anesthetized. In patients who are unconscious or anesthetized, hyperventilation may be induced using a standard operating room or ICU ventilator. The monitoring of a patient's temperature and arterial blood gas values may be accomplished using procedures that are routine in the art.
The present methods will typically be used for cooling patients prior to cardiac or neurosurgery. They may also be used to rapidly lower the body temperature of patients suffering from hemorrhagic shock or in an emergency room setting for rapidly rewarming hypothermic patients. In general, the procedures may be performed on all patients in whom core temperature changes are desired, with the possible exception of those with asthma. In these patients, there is a risk of inducing bronchospasm and the risk/benefit ratio of using the techniques will need to be considered on a case by case basis.
In order to cool a patient, the breathing mixture to be inhaled must be cooled below the patient's body temperature; the colder the inhaled breathing gas, the higher the resulting respiratory heat loss. In order to warm a patient, the breathing mixture to be inhaled will be warmed; the warmer the inhaled breathing gas, the higher the resulting respiratory heat gain.
In addition, the content of water vapor in the breathing mixture to be inhaled can be changed to improve the efficiency of the method. For example, the content of water vapor can be decreased (e.g., down to zero) if the patient needs to be cooled; the drier the breathing mixture, the higher the evaporative heat loss. Alternatively, the content of water vapor can be increased (up to saturation) if the patient needs to be rewarmed. This will have the effect of minimizing evaporative heat loss.
In a preferred method, patients are heated or warmed using eucapnic hyperventilation with about an 80/20 sulfur hexafluoride-oxygen mixture. To cool a patient, hyperventilation is performed with a gas mixture to which C02 is added to maintain isocapnia. The gas mixture is delivered dry and at subfreezing temperature through an endotracheal tube of the type routinely used in operations. To rewarm a patient, hyperventilation is performed with a humidified and warmed gas mixture.
The gas mixtures administered to patients may be mixed in a reservoir and then delivered to patients by means of a ventilator of the sort commonly available in hospitals. In procedures designed to lower body temperature, the gas mixture may be forced through a desiccator to remove water vapor and through a heat exchanger to lower its temperature (see e.g., Beran, et al., J. App. Physiol. 39:337-340 (1975)). In procedures designed to increase body temperature, gases from a mixing reservoir may be delivered using a ventilator, humidified, and warmed by a standard electrically operated heater/humidifier system. As with cooling, rewarming will be accomplished using a gas mixture of sulfur hexafluoride and oxygen. These procedures are merely illustrative and the invention is compatible with any other method for heating or cooling gas mixtures and for effectively delivering them to a patient.
The simplest way for achieving hyperventilation will be by means of the voluntary cooperation of a patient immediately prior to their being anesthetized. In patients who are unconscious or anesthetized, hyperventilation may be induced using a standard operating room or ICU ventilator. The monitoring of a patient's temperature and arterial blood gas values may be accomplished using procedures that are routine in the art.
The present methods will typically be used for cooling patients prior to cardiac or neurosurgery. They may also be used to rapidly lower the body temperature of patients suffering from hemorrhagic shock or in an emergency room setting for rapidly rewarming hypothermic patients. In general, the procedures may be performed on all patients in whom core temperature changes are desired, with the possible exception of those with asthma. In these patients, there is a risk of inducing bronchospasm and the risk/benefit ratio of using the techniques will need to be considered on a case by case basis.
Claims (24)
1. A method of reducing the body temperature of a patient for any clinical condition in which such a change is desirable, comprising:
a) administering a gas mixture to said patient by hyperventilation, wherein:
i) said gas mixture comprises a combination of sulfur hexafluoride and oxygen;
ii) said gas mixture is administered at a temperature below the body temperature of said patient; and b) maintaining the administration of the gas mixture of step a) until said patient's body temperature is reduced.
a) administering a gas mixture to said patient by hyperventilation, wherein:
i) said gas mixture comprises a combination of sulfur hexafluoride and oxygen;
ii) said gas mixture is administered at a temperature below the body temperature of said patient; and b) maintaining the administration of the gas mixture of step a) until said patient's body temperature is reduced.
2. The method of claim 1, wherein said sulfur hexafluoride is present at a concentration of 20-80%.
3. The method of claim 1, wherein said sulfur hexafluoride is present at a concentration of about 80%.
4. The method of claim 1, wherein the concentration of carbon dioxide in said patient's blood is maintained in the normal range.
5. The method of claim 1, wherein the water vapor content of said gas mixture is less than 10%.
6. The method of claim 1, wherein said patient is cooled in preparation for or during surgery.
7. The method of claim 6, wherein said surgery is cardiac or neurosurgery.
8. The method of claim 1, wherein said patient is cooled as a treatment for hemorrhagic shock.
9. A method of increasing the body temperature of a patient for any clinical condition in which such a change is desirable, comprising:
a) administering a gas mixture to said patient by hyperventilation, wherein:
i) said gas mixture comprises a combination of sulfur hexafluoride and oxygen;
ii) said gas mixture is administered at a temperature above the body temperature of said patient; and b) maintaining the administration of the gas mixture of step a) until said patient's body temperature is increased.
a) administering a gas mixture to said patient by hyperventilation, wherein:
i) said gas mixture comprises a combination of sulfur hexafluoride and oxygen;
ii) said gas mixture is administered at a temperature above the body temperature of said patient; and b) maintaining the administration of the gas mixture of step a) until said patient's body temperature is increased.
10. The method of claim 9, wherein said sulfur hexafluoride is present at a concentration of 20-80%.
11. The method of claim 9, wherein said sulfur hexafluoride is present at a concentration of about 80%.
12. The method of claim 9, wherein the pressure of carbon dioxide in said patient's arterial blood is maintained in the normal range.
13. The method of claim 9, wherein the water vapor content of said gas mixture is greater than 20%.
14. The method of claim 9, wherein the water vapor content of said gas mixture is greater than 40%.
15. The method of claim 9, wherein the body temperature of said patient is increased as a treatment for hypothermia.
16. A composition for rapidly changing the body temperature of a patient, comprising sulfur hexafluoride and oxygen.
17. The composition of claim 16, wherein said sulfur hexafluoride is present at a concentration of 20-80%.
18. The composition of claim 16, wherein said sulfur hexafluoride is present at a concentration of about 80%.
19. The composition of claim 16, wherein the water vapor content of said composition is less than 10%.
20. The composition of claim 17, wherein the water vapor content of said composition is less than 10%.
21. The composition of claim 16, wherein the water vapor content of said composition is greater than 20%.
22. The composition of claim 17, wherein the water vapor content of said composition is greater than 20%.
23. The composition of claim 16, wherein the water vapor content of said composition is greater than 40%.
24. The composition of claim 17, wherein the water vapor content of said composition is greater than 40%.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9052198P | 1998-06-24 | 1998-06-24 | |
| US60/090,521 | 1998-06-24 | ||
| PCT/US1999/013878 WO1999066938A1 (en) | 1998-06-24 | 1999-06-22 | Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2335939A1 true CA2335939A1 (en) | 1999-12-29 |
Family
ID=22223152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002335939A Abandoned CA2335939A1 (en) | 1998-06-24 | 1999-06-22 | Composition containing sulfur hexafluoride and oxygen, for increasing or decreasing the body temperature of a patient |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6303156B1 (en) |
| EP (1) | EP1089743A1 (en) |
| JP (1) | JP2002518453A (en) |
| CA (1) | CA2335939A1 (en) |
| WO (1) | WO1999066938A1 (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6719779B2 (en) | 2000-11-07 | 2004-04-13 | Innercool Therapies, Inc. | Circulation set for temperature-controlled catheter and method of using the same |
| US6585752B2 (en) | 1998-06-23 | 2003-07-01 | Innercool Therapies, Inc. | Fever regulation method and apparatus |
| US7458984B2 (en) * | 1998-01-23 | 2008-12-02 | Innercool Therapies, Inc. | System and method for inducing hypothermia with active patient temperature control employing catheter-mounted temperature sensor and temperature projection algorithm |
| US6974463B2 (en) | 1999-02-09 | 2005-12-13 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
| US6383210B1 (en) | 2000-06-02 | 2002-05-07 | Innercool Therapies, Inc. | Method for determining the effective thermal mass of a body or organ using cooling catheter |
| US6599312B2 (en) | 1998-03-24 | 2003-07-29 | Innercool Therapies, Inc. | Isolated selective organ cooling apparatus |
| US6576002B2 (en) | 1998-03-24 | 2003-06-10 | Innercool Therapies, Inc. | Isolated selective organ cooling method and apparatus |
| US7914564B2 (en) * | 1999-02-09 | 2011-03-29 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
| US6830581B2 (en) | 1999-02-09 | 2004-12-14 | Innercool Therspies, Inc. | Method and device for patient temperature control employing optimized rewarming |
| US6648906B2 (en) | 2000-04-06 | 2003-11-18 | Innercool Therapies, Inc. | Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid |
| EP1453524A2 (en) * | 2001-12-04 | 2004-09-08 | Minnesota High-Tech Resources, LLC | Breathable gas mixtures to change body temperature |
| WO2003059425A1 (en) * | 2002-01-09 | 2003-07-24 | The Brigham And Women's Hospital, Inc. | Method for altering the body temperature of a patient using a nebulized mist |
| WO2004082729A2 (en) * | 2003-03-17 | 2004-09-30 | Aga Ab | Method and apparatus for changing the body temperature of a mammal |
| US20050154430A1 (en) * | 2004-01-09 | 2005-07-14 | Benecool, Inc. | Transpulmonary systemic cooling using liquid mists |
| US20050152844A1 (en) * | 2004-01-09 | 2005-07-14 | Barbut Denise R. | Transpulmonary systemic cooling using liquid mists |
| US8100123B2 (en) * | 2004-01-22 | 2012-01-24 | Thermocure, Inc. | Respiratory system for inducing therapeutic hypothermia |
| WO2005113046A2 (en) * | 2004-05-20 | 2005-12-01 | The Brigham And Women's Hospital, Inc. | Method for decreasing body temperature based upon latent heat of fusion |
| US9358150B2 (en) | 2005-05-13 | 2016-06-07 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
| US7824436B2 (en) * | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
| US8721699B2 (en) | 2005-05-13 | 2014-05-13 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
| US20090047447A1 (en) * | 2005-08-02 | 2009-02-19 | Sawin Herbert H | Method for removing surface deposits and passivating interior surfaces of the interior of a chemical vapor deposition reactor |
| US8124329B2 (en) * | 2008-05-14 | 2012-02-28 | Sheleg Sergey V | Hypothermic preservation of biological tissues and cells |
| US20100174278A1 (en) * | 2008-11-07 | 2010-07-08 | Denise Barbut | Methods of nasopharyngeal cooling for augmenting coronary perfusion pressure |
| JP2012530554A (en) | 2009-06-19 | 2012-12-06 | ベネチル・インコーポレイテッド | Device for cooling the nasal cavity |
| WO2011103208A2 (en) * | 2010-02-16 | 2011-08-25 | The Johns Hopkins University | Method and device for non-invasive anatomical and systemic cooling and neuroprotection |
| CN104010598B (en) | 2011-09-05 | 2015-12-09 | 库尔诊疗公司 | For causing, the hypothermic pogonip stomach of therapeutic is sent, dermal delivery or peritoneum are sent |
| US10238831B2 (en) | 2013-09-08 | 2019-03-26 | Qool Therapeutics, Inc. | Temperature measurement and feedback for therapeutic hypothermia |
| US9629889B2 (en) * | 2014-10-22 | 2017-04-25 | Khanh Le | Aqueous solution formulated to raise body temperature |
| EP3261593B1 (en) | 2015-02-23 | 2021-11-03 | Qool Therapeutics, Inc. | Systems and methods for endotracheal delivery of frozen particles |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2072241C1 (en) * | 1995-09-20 | 1997-01-27 | Панина Елена Владимировна | Method and device for preparing inhalation gas mixture |
-
1999
- 1999-06-22 US US09/337,506 patent/US6303156B1/en not_active Expired - Fee Related
- 1999-06-22 CA CA002335939A patent/CA2335939A1/en not_active Abandoned
- 1999-06-22 EP EP99928807A patent/EP1089743A1/en not_active Withdrawn
- 1999-06-22 JP JP2000555624A patent/JP2002518453A/en not_active Ceased
- 1999-06-22 WO PCT/US1999/013878 patent/WO1999066938A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1089743A1 (en) | 2001-04-11 |
| US6303156B1 (en) | 2001-10-16 |
| WO1999066938A1 (en) | 1999-12-29 |
| JP2002518453A (en) | 2002-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6303156B1 (en) | Noninvasive method for increasing or decreasing the body temperature of a patient | |
| US6983749B2 (en) | Inducing hypothermia and rewarming using a helium-oxygen mixture | |
| Walker et al. | HEAT AND WATER EXCHANGE IN THE RESPIRATORY TRACTT | |
| US7201163B2 (en) | Method for altering the body temperature of a patient using a nebulized mist | |
| US11523937B2 (en) | Method and device for non-invasive anatomical and systemic cooling and neuroprotection | |
| US20150351955A1 (en) | Respiratory system for inducing therapeutic hypothermia | |
| US20070162097A9 (en) | Patient cooling system and method | |
| Wilson et al. | Intratracheal pulmonary ventilation and congenital diaphragmatic hernia: A report of two cases | |
| RASHAD et al. | Role of humidity in prevention of hypothermia in infants and children | |
| Goldberg et al. | Do heated humidifiers and heat and moisture exchangers prevent temperature drop during lower abdominal surgery? | |
| WO2004082729A2 (en) | Method and apparatus for changing the body temperature of a mammal | |
| ZIMPFER | Forced-air warming maintains normothermia during orthotopic liver transplantation | |
| CA2169608C (en) | Medical gas mixture | |
| Crockett et al. | Assessment of ventilation during the performance of a percutaneous dilatational tracheostomy: hypoventilation is not a common complication | |
| Poppelbaum | Rediscovery of air for anaesthesia in thoracic surgery | |
| US11957617B2 (en) | Method and device for non-invasive anatomical and systemic cooling and neuroprotection | |
| US20230181353A1 (en) | Method and device for non-invasive anatomical and systemic cooling and neuroprotection | |
| Connaughton et al. | Prolonged hypothermia below 25° C. for periods over 20 hours: Influence of therapy and technique on survival | |
| Brittain | Trichlorethylene (Trilene) as an Anesthetic in Neurosurgery. | |
| Xia | General Anesthetic Techniques in Oral and Maxillofacial Surgery | |
| Bewley et al. | Closed circuit anaesthesia in ventilated patients using the Komesaroff vaporizer within the circle | |
| Wesley et al. | Use of venturi entrainment mask for high-flow ventilation of patients submitting to ophthalmic surgery under local anesthesia | |
| KOLB et al. | ANESTHESIA IN DOGS DURING HYPOTHERMIA BELOW 20° C | |
| TUGNOLI | ANESTHESIA IN NEUROSURGERY | |
| Jani et al. | Prevention of body temperature reduction (afterdrop) following hypothermic perfusion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |